The global Protein Detection and Quantification Market size was estimated to be USD 2.72 billion in 2023 and is expected to reach USD 7.10 billion by 2034 with a CAGR of 9.11% during the forecast period 2024-2034. Increased funding in biotechnology and pharmaceutical research, Growing Prevalence of Chronic Diseases, Technological Advancements, expanding field of proteomics, Supportive regulatory frameworks and guidelines, and Automation in laboratories improve efficiency and accuracy will drive market growth.
In January 2024, Agilent Technologies Inc. announced the launch of the Agilent ProteoAnalyzer machine, an automated parallel capillary electrophoresis machine designed to analyze complex protein mixtures. This innovative technology enhances protein detection capabilities by streamlining workflows and improving the accuracy of protein separation and quantification. The introduction of such advanced systems is a significant driver in the protein detection and quantification market, as it addresses the growing demand for efficient and reliable analysis tools in both clinical and research settings.
By technology, the colorimetric assays segment accounted for the highest revenue-grossing segment in the global protein detection and quantification market in 2023 owing to the ease of use, cost-effectiveness, and high sensitivity of these assays, making them a preferred choice for many laboratories and research institutions. For instance, on April 26, 2023, Agilent Technologies Inc. announced the signing of a Memorandum of Understanding (MOU) with Theragen Bio in South Korea to improve precision oncology by advancing bioinformatics solutions. Agilent and Theragen Bio will collaborate on cancer genomic profiling (CGP) design, engineering understanding, and software skills to drive targeted analysis capabilities and speed treatment decisions. Additionally, the immunological methods segment is predicted to grow at the fastest CAGR during the forecast period owing to the increasing demand for specific and sensitive detection of proteins and biomarkers in various applications, including disease diagnosis and therapeutic monitoring.
By product, the kits and reagents/consumables segment accounted for the highest revenue-grossing segment in the global protein detection and quantification market in 2023 owing to the growing reliance on ready-to-use solutions that streamline experimental processes and enhance reproducibility in protein analysis. For instance, Alamar Biosciences, a company that uses precision proteomics to enable early disease detection, announced today the commercial launch of the ARGO HT System for push-button, high sensitivity protein analysis in biofluids and the NULISAseq Inflammation Panel 250 for deep immune response profiling. The ARGO HT System automates NULISA™ assays in under 30 minutes, minimizing variability and saving researchers' valuable time. Additionally, the services segment is predicted to grow at the fastest CAGR during the forecast period owing to the increasing demand for outsourced expertise in protein analysis and the rising complexity of proteomic studies requiring specialized services and support.
By application, the drug discovery and development segment accounted for the highest revenue-grossing segment in the global protein detection and quantification market in 2023 owing to the critical role of protein analysis in identifying and validating drug targets, as well as in assessing therapeutic efficacy. For instance, in October 2023, Thermo Fisher Scientific Inc. announced the acquisition of Olink Holdings AB, a company that offers next-generation proteomics solutions for advanced proteomics discovery and development, which is expected to assist biopharmaceutical researchers in understanding diseases at the protein level. Additionally, the clinical diagnosis segment is predicted to grow at the fastest CAGR during the forecast period owing to the increasing emphasis on early disease detection and the growing need for personalized medicine approaches that rely on precise protein analysis.
By end-user, the hospitals and diagnostic centers segment accounted for the highest revenue-grossing segment in the global protein detection and quantification market in 2023 owing to the rising number of diagnostic tests performed and the growing need for accurate and timely patient care. For instance, on March 7, 2023, Danaher Corporation, a global science and technology pioneer, established a strategic agreement with the University of Pennsylvania (Penn) aimed at cell therapy research. This multi-year collaboration intends to create innovative technologies that will improve the consistency of therapeutic outcomes for patients and eliminate manufacturing constraints in the supply of next-generation tailored cells. Additionally, the contract research organizations segment is predicted to grow at the fastest CAGR during the forecast period owing to the increasing demand for outsourced research services and the need for efficient drug development processes in the biopharmaceutical industry.
North American region is anticipated for the highest revenue share during the forecast period owing to the presence of leading biotechnology and pharmaceutical companies, advanced healthcare infrastructure, and significant investments in research and development. Additionally, the Asia Pacific region is predicted to grow at the fastest CAGR during the forecast period owing to the increasing investments in healthcare infrastructure, the rising prevalence of chronic diseases, and the growing demand for advanced diagnostic technologies. For instance, in April 2024, Thermo Fisher Scientific announced the release of a new high-throughput protein quantification platform aimed at streamlining research workflows in drug discovery and development. This novel technology combines advanced mass spectrometry with automated sample handling, dramatically increasing throughput and accuracy for researchers in North America.
This comprehensive research report focuses on the global and regional market size and forecasts from 2023 to 2034.
In January 2024, Agilent Technologies Inc. announced the launch of the Agilent ProteoAnalyzer machine, an automated parallel capillary electrophoresis machine designed to analyze complex protein mixtures. This innovative technology enhances protein detection capabilities by streamlining workflows and improving the accuracy of protein separation and quantification. The introduction of such advanced systems is a significant driver in the protein detection and quantification market, as it addresses the growing demand for efficient and reliable analysis tools in both clinical and research settings.
By technology, the colorimetric assays segment accounted for the highest revenue-grossing segment in the global protein detection and quantification market in 2023 owing to the ease of use, cost-effectiveness, and high sensitivity of these assays, making them a preferred choice for many laboratories and research institutions. For instance, on April 26, 2023, Agilent Technologies Inc. announced the signing of a Memorandum of Understanding (MOU) with Theragen Bio in South Korea to improve precision oncology by advancing bioinformatics solutions. Agilent and Theragen Bio will collaborate on cancer genomic profiling (CGP) design, engineering understanding, and software skills to drive targeted analysis capabilities and speed treatment decisions. Additionally, the immunological methods segment is predicted to grow at the fastest CAGR during the forecast period owing to the increasing demand for specific and sensitive detection of proteins and biomarkers in various applications, including disease diagnosis and therapeutic monitoring.
By product, the kits and reagents/consumables segment accounted for the highest revenue-grossing segment in the global protein detection and quantification market in 2023 owing to the growing reliance on ready-to-use solutions that streamline experimental processes and enhance reproducibility in protein analysis. For instance, Alamar Biosciences, a company that uses precision proteomics to enable early disease detection, announced today the commercial launch of the ARGO HT System for push-button, high sensitivity protein analysis in biofluids and the NULISAseq Inflammation Panel 250 for deep immune response profiling. The ARGO HT System automates NULISA™ assays in under 30 minutes, minimizing variability and saving researchers' valuable time. Additionally, the services segment is predicted to grow at the fastest CAGR during the forecast period owing to the increasing demand for outsourced expertise in protein analysis and the rising complexity of proteomic studies requiring specialized services and support.
By application, the drug discovery and development segment accounted for the highest revenue-grossing segment in the global protein detection and quantification market in 2023 owing to the critical role of protein analysis in identifying and validating drug targets, as well as in assessing therapeutic efficacy. For instance, in October 2023, Thermo Fisher Scientific Inc. announced the acquisition of Olink Holdings AB, a company that offers next-generation proteomics solutions for advanced proteomics discovery and development, which is expected to assist biopharmaceutical researchers in understanding diseases at the protein level. Additionally, the clinical diagnosis segment is predicted to grow at the fastest CAGR during the forecast period owing to the increasing emphasis on early disease detection and the growing need for personalized medicine approaches that rely on precise protein analysis.
By end-user, the hospitals and diagnostic centers segment accounted for the highest revenue-grossing segment in the global protein detection and quantification market in 2023 owing to the rising number of diagnostic tests performed and the growing need for accurate and timely patient care. For instance, on March 7, 2023, Danaher Corporation, a global science and technology pioneer, established a strategic agreement with the University of Pennsylvania (Penn) aimed at cell therapy research. This multi-year collaboration intends to create innovative technologies that will improve the consistency of therapeutic outcomes for patients and eliminate manufacturing constraints in the supply of next-generation tailored cells. Additionally, the contract research organizations segment is predicted to grow at the fastest CAGR during the forecast period owing to the increasing demand for outsourced research services and the need for efficient drug development processes in the biopharmaceutical industry.
North American region is anticipated for the highest revenue share during the forecast period owing to the presence of leading biotechnology and pharmaceutical companies, advanced healthcare infrastructure, and significant investments in research and development. Additionally, the Asia Pacific region is predicted to grow at the fastest CAGR during the forecast period owing to the increasing investments in healthcare infrastructure, the rising prevalence of chronic diseases, and the growing demand for advanced diagnostic technologies. For instance, in April 2024, Thermo Fisher Scientific announced the release of a new high-throughput protein quantification platform aimed at streamlining research workflows in drug discovery and development. This novel technology combines advanced mass spectrometry with automated sample handling, dramatically increasing throughput and accuracy for researchers in North America.
This comprehensive research report focuses on the global and regional market size and forecasts from 2023 to 2034.
Report Scope:
- Base Year: 2023
- Forecast Period: 2024-2034
- Study Coverage
- Market Forecast by Technology, Product, Application, and End-User
- Market Forecast for 5 Regions and 17+ Countries
- North America (U.S. and Canada)
- Europe (Germany, France, UK, Spain, Italy, Russia, Rest of Europe)
- Asia Pacific (China, Japan, India, Australia, South Korea, Rest of APAC)
- Latin America (Brazil, Mexico, Argentina, Rest of LATAM)
- MEA (South Africa, GCC, Rest of MEA)
- Exhaustive Company Profiles of the Top 10+ Major Market Players
- 20% Free Customization Available to Meet Your Exact Requirement.
Segmentation: Protein Detection and Quantification Market Report 2023 - 2034
Protein Detection and Quantification Market Analysis & Forecast by Technology 2023 - 2034 (Revenue USD Bn)
- Colorimetric Assays
- Immunological Methods
- Chromatography
- Mass Spectrometry
- Others
Protein Detection and Quantification Market Analysis & Forecast by Product 2023 - 2034 (Revenue USD Bn)
- Kits and Reagents/Consumables
- Instruments
- Services
Protein Detection and Quantification Market Analysis & Forecast by Application 2023 - 2034 (Revenue USD Bn)
- Drug Discovery and Development
- Clinical Diagnosis
- Others
Protein Detection and Quantification Market Analysis & Forecast by End-User 2023 - 2034 (Revenue USD Bn)
- Academic Research Institutes
- Biotechnology and Pharmaceutical Companies
- Contract Research Organizations
- Hospitals and Diagnostic Centers
- Others
Protein Detection and Quantification Market Analysis & Forecast by Region 2023 - 2034 (Revenue USD Bn)
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- UK
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of LATAM
- Middle East & Africa
- South Africa
- GCC
- Rest of MEA
Table of Contents
1. Research Methodology
2. Introduction
4. Market Environment Analysis
5. Market Dynamics
7. Protein Detection and Quantification Market: Technology Estimates & Trend Analysis
8. Protein Detection and Quantification Market: Product Estimates & Trend Analysis
9. Protein Detection and Quantification Market: Application Estimates & Trend Analysis
10. Protein Detection and Quantification Market: End-User Estimates & Trend Analysis
11. Regional Market Analysis
12. North America Protein Detection and Quantification Market
13. Europe Global Protein Detection and Quantification Market
14. Asia Pacific Global Protein Detection and Quantification Market
15. Latin America Global Protein Detection and Quantification Market
16. MEA Global Protein Detection and Quantification Market
17. Competitor Analysis
18. Company Profiles
Companies Mentioned
- Thermo Fisher Scientific
- Agilent Technologies
- Bio-Rad Laboratories
- Merck KGaA
- Roche Diagnostics
- GE Healthcare
- PerkinElmer
- Luminex Corporation
- Abcam plc
- Promega Corporation
- MilliporeSigma
- Pierce Biotechnology (part of Thermo Fisher)
- QIAGEN
- Waters Corporation
- Biorad.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 200 |
| Published | December 2024 |
| Forecast Period | 2023 - 2034 |
| Estimated Market Value ( USD | $ 2.72 Billion |
| Forecasted Market Value ( USD | $ 7.1 Billion |
| Compound Annual Growth Rate | 9.1% |
| Regions Covered | Global |
| No. of Companies Mentioned | 15 |
